Global Proteomics | Next-Generation Proteomics | Large-Scale Proteomics

Powering precision medicine into reality

The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making.

OUR STORY

Transformative Insights from Discovery to Clinic

Unbiased biological insights from tissue and biofluids

Novel drug target identification and validation

Custom panels for absolute protein quantification

Biognosys is the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development.

OUR SERVICES

High Performance Software, Peptide Kits, and Sample Preparation Reagents

Our software solutions for proteomics include Spectronaut® for DIA proteomics, SpectroDive™ for Targeted Proteomics, SpectroMine™ for DDA proteomics, and our free-of-charge QC tool QuiC™.

 

 

OUR SOFTWARE

Our peptide kits and reagents empower researchers to apply cutting-edge proteomics in-house. Discover our PQ500™ Reference Peptides for plasma proteomics quantification, our iRT kit for quality control, and our sample preparations kits.

 

OUR KITS

Latest News & Stories

News
Biognosys Presenting Novel Cancer Research on its Proteomics Platforms and Advancing Data Analysis with the Launch of Proteoverse™ at the AACR Annual Meeting 2023

In collaboration with prominent biopharma companies and academic institutions, Biognosys will demonstrate the technological advances and versatility of the TrueDiscovery™,[...]

READ MORE
News
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics, expected to[...]

READ MORE
News
Biognosys Releases TrueTarget™ Technology Update that Enables More Effective Biopharma Drug Discovery

The improved Limited Proteolysis Mass Spectrometry (LiP-MS) proteomics technology allows for better identification of drug[...]

READ MORE
News
Biognosys Launches New Version of Spectronaut® at HUPO International Proteomics Congress

Spectronaut 17 features directDIA+™, the best-performing library-free workflow for DIA proteomics available on the[...]

READ MORE
Conferences & Events
Biognosys’ Cambridge (MA) Office Inauguration Event

Biognosys opens US offices in Cambridge (MA) with ribbon cutting ceremony, champagne mixer, and vast scientific program featuring collaborators NeoGenomics, and[...]

READ MORE
News
Biognosys to Present at ALDA Fall 2022 Senior Executive Conference on Trends in Pharma Discovery & Manufacturing

Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today that they are participating in the ALDA (Analytical, Life Science[...]

READ MORE
News
Biognosys Expands Its Global Presence with a US Office in Biopharma Hub Cambridge, Massachusetts

The expansion is part of the company’s growth strategy for North America and will foster collaboration with life science companies and academia. An inauguration event will take[...]

READ MORE
News
Biognosys to Participate in Capital One Spatial Biology & Proteomics Healthcare Disruptors Summit

Biognosys announced today that they are participating in the upcoming Capital One Spatial Biology & Proteomics Healthcare Disruptors Summit, taking place virtually on Wednesday,[...]

READ MORE
Resource - Launch Pages
SpectroDive™ 11: Straightforward Validation of Your Protein Targets

SpectroDive 11 makes your targeted proteomics analysis easer than[...]

READ MORE

Our technological innovation and scientific expertise are fueled by an extensive network of over 25 collaborators across the life science industry and academia.

 

Our Collaborators

Join Email List

    Select any of the below topic preferences: By submitting this form, you confirm that you agree to the processing of your personal data by Biognosys as described in the Privacy Notice.

    Join the Biognosys email list to receive news and exclusive content.

    Join Email List

      Select any of the below topic preferences: By submitting this form, you confirm that you agree to the processing of your personal data by Biognosys as described in the Privacy Notice.

      Helpdesk

      Access our knowledge base with relevant resources and guiding information.

      Access

      Contact

        Close banner

        Biognosys at #AACR23

        Eight Posters Now Available

        Biognosys at the AACR Annual Meeting 2023

        Eight Posters Now Available

        Download Now